Navigation Links
Daytrana in Medical News

New analysis shows DAYTRANA offered ADHD symptom control for 12 months

Washington, D.C. May 7, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA (methylphenidate transdermal system) between boys and girls aged 6...

Long-term 12-month safety data on ADHD patch DAYTRANA

BOSTON OCTOBER 25, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRA...

Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom

DAYTRANA (methylphenidate transdermal system), formulated by Shire was the foremost patch medication approved to treat symptoms of ADHD in children//. Transdermal formulation of methylphenidate - DAYTRANA, is now available in pharmacies in varying doses such as 10 mg, 15 mg, 20 mg and 30 mg. ...

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

.../recall of thirty-nine (39) lots of the ADHD patch daytrana (the lots of daytrana patches affected by this action are listed below). Shire is taking this action because some daytrana patches no longer meet their release liner removal...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track

... 10.6(3) n/a n/a 2% daytrana 9.4 -5% 64% ...to be recognized into revenue by the end of 2007. daytrana - ADHD DAYTRANA's average share of the US ADHD ma...the US ADHD market resulted in US prescriptions of daytrana for the three months to September 30, 2007 being u...

Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

...e Effect Size in Children with ADHD Poster# E58 daytrana (methylphenidate transdermal system): October 25...Information go to http://www.vyvanse.com . About daytrana Tell your doctor about any heart conditions, incl...t heart problems, such as chest pain or fainting. daytrana should not be used if the child has: significant a...
Daytrana in Medical Technology

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

...m) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). A request from European regulators to conduct an additional clinical study on daytrana in a European patient population combined with the recently announced planned acquisition of the worldwide rights (excluding the US, Canada and Barbad...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

...D). The findings from the analysis reaffirmed that daytrana has an established safety profile and effectively ...n, D.C. "This analysis further demonstrates that daytrana has a recognized safety profile and is an effectiv... decreased weight. In the study, the efficacy of daytrana was measured using the ADHD Rating Scale (ADHD-RS-...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

...ractivity Disorder (ADHD) patch, demonstrated that daytrana provided significant ADHD tolerability and symptom...ective ADHD symptom control improvement when using daytrana for 12 months, improving their ability to maintain...a. "Importantly, this year- long study showed that daytrana maintained a favorable safety profile throughout t...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...ctivity Disorder APA Poster# NR750 daytrana (methylphenidate transdermal system): May 23...tite, insomnia, headache, and weight loss. About daytrana daytrana should not be used in patients with allergy to met...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

...D experienced effective ADHD treatment with use of daytrana for 12 months, sustaining the improvements in thei... Pittsburgh School of Medicine. "More importantly, daytrana maintained a favorable safety profile, meeting the... and other stimulants in this class." Shire's daytrana is the first and only patch medication approved by...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

...agnosed and, therefore, undertreated. Shire's daytrana is the first and only patch medication approved by...e symptoms of ADHD in children aged 6 to 12 years. daytrana is available in four dosage strengths - 10 mg, 15 ...dy's primary endpoint. The 58 boys that received daytrana averaged a significant 56 percent ADHD- RS-IV tota...
Daytrana in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 67.4 -77% -77% -48% 11.0% daytrana 14.9 -34% -34% ...ADDERALL XR to Teva in the URA calculation. daytrana - ADHD Product sales of daytrana for the three months to June 30, 2009 decreased by...

Shire begins the year with a strong performance

...-promotion of LIALDA in the US. Pipeline daytrana - for the treatment of ADHD in children in the EU ...he MAA does not impact Shire's commitment to daytrana in the US where the product has been used as...the US in the fourth quarter of 2009; - daytrana for the treatment of ADHD in adolescents in the US...

Publication of Shire plc's Annual Report 2008

...VANT in certain EU countries; - the launch of daytrana (EU and Canada); - the continued roll out of ...oval; six in the US (FOSRENOL and EQUETRO in 2004, daytrana and ELAPRASE in 2006, LIALDA and VYVANSE in 2007) ...atory filing for VYVANSE in Europe in 2010. daytrana for ADHD in EU & Canada Regulatory subm...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ucting additional clinical outcomes trials; - daytrana (methylphenidate transdermal system) for use in th... 318.9 +317% +388% 8.2% daytrana 78.7 +23% -11% ...n 2007) and a price increase in April 2008. daytrana - ADHD Product sales for the year to Decemb...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... 96.0 806% n/a 9.0% daytrana 18.1 93% -14% ... of 10.2%, based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Sep... of DAYTRANA. No interruption in the production of daytrana is anticipated. Shire and Noven may take additiona...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... 65.2 n/a n/a 7.4% daytrana 22.6 14% -11% ...re of 8.2% based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Jun...nounced a voluntary recall of a limited portion of daytrana patches because certain patches did not meet their...

Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced

...voluntary recall of two (2) lots of the ADHD patch daytrana (lots 2750211 and 2764111). Shire is taking this a...while being opened. The current supply levels of daytrana should be sufficient to ensure that patients can continue to have their daytrana prescriptions filled at their local pharmacy. Nove...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...have difficulty removing the release liner of some daytrana patches, similar to the concerns which led to a voluntary market withdrawal of a limited number of daytrana patches in September 2007. Shire and Noven continu...for use in adult patients in the US in Q2 2008; - daytrana in the EU during H1 2009; - INTUNIV in the US dur...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... 76.5 - N/A N/A daytrana 64.2 25.1 +156 +...to revenue during the year to December 31, 2007. daytrana - ADHD Product sales for the year to December 31...NA was launched in June 2006). US prescriptions of daytrana for the year to December 31, 2007 over 2006 benefi...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...nto new geographies. These products, together with daytrana that was launched last year, represented 32% of ou... patients, of which 7.5 million are untreated. - daytrana - ADHD - Regulatory submissions were filed for app...US in Q2 2008 (PDUFA date April 28, 2008); - daytrana in the EU during H1 2009; - INTUNIV in the US dur...
Other Tags
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... disease has been a rapidly evolving pursuit with ... crook in the research road, scientists have found ... associated with the disease. The report, which appears ... could have important implications for developing novel treatments. ... explain that for years, research has suggested a ...
(Date:4/22/2014)... decades researchers have characterized a set of clock genes ... all types of species, from flies to humans. Over ... surmise there are more. A team from the Perelman ... if big-data approaches could find them. , To ... PhD, professor of Pharmacology and first author Ron Anafi, ...
(Date:4/22/2014)... The risk of pregnancy among women using a ... more than 10 times greater over a 10-year period ... study by researchers at Yale University and UC Davis ... medical journal Contraception , the study found the ... marketed under the brand name Essure. , "This ...
(Date:4/22/2014)... NY, April 22, 2014Hemoglobin A1c is the standard measurement ... diabetes. Blood levels of A1c are typically measured every ... developed a data-based model that accurately estimates A1c using ... Diabetes Technology & Therapeutics ( DTT ), a ... article is available free on the DTT ...
Breaking Medicine News(10 mins):Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3
(Date:4/23/2014)... 23, 2014 A biomedical engineer at the University ... technology to make blood transfusions safer. His work is ... Institutes of Health (NIH). , Blood transfusions save ... modern medicine,s absolute necessities. Without them, for instance, routine ... are perfect, however. There,s strong evidence that transfusions of ...
(Date:4/23/2014)... is leading a 2 million Food Standards Agency (FSA) ... premises and industry workers. , Norovirus outbreaks can ... a batch of frozen strawberries infected 11,000 people in ... understanding of which strains cause infection and which foods ... , Researchers will produce data that will help ...
(Date:4/22/2014)... Fla. (April 21, 2014) -- There are all sorts ... feathers and spread their colorful tails; satin bowbirds build ... blue and shiny objects; and European bitterling males show ... has evolved a unique method to communicate with others. ... "Signaling can have profound fitness implications for ...
Breaking Biology News(10 mins):UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Best practices in communication for the animal world 2Best practices in communication for the animal world 3
Other Contents